Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Diagnosing & Caring for Patients with Fibromyalgia

Lara C. Pullen, PhD  |  May 19, 2022

Noting that a diagnosis of fibromyalgia is often missed in men, Doebl et al. say their study data indicate an urgent need exists for a model of care for patients with fibromyalgia. Stefanie Doebl, a graduate student at the University of Aberdeen, U.K., and colleagues call for an approach that ensures prompt diagnosis, access to evidence-based care and long-term support for patients. They published their results in the June 2021 issue of Arthritis Care & Research.1

Study Design

The investigators began their study by contacting people who had responded to the maintaining musculoskeletal health (MamMOTH) screening survey. In the MamMOTH clinical trial, researchers recruited patients without chronic, widespread pain who were at risk of developing chronic widespread pain, defined as having regional pain, sleep disturbances, multiple somatic symptoms and/or certain illness behaviors.2 Individuals were invited to take part in the current study if they had responded to the MamMOTH screening questionnaire and indicated a willingness for future contact. Not all individuals included in the study had fibromyalgia symptoms and not all the individuals who had fibromyalgia symptoms had been diagnosed with fibromyalgia.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In 2010, the ACR released new preliminary criteria for fibromyalgia.3 The criteria removed tender points as the central element of the fibromyalgia definition, identified the importance of the widespread pain index, incorporated key fibromyalgia symptoms into the criteria and provided severity scales to measure the extent of widespread pain and symptom severity. The new criteria made it possible to evaluate fibromyalgia as a continuum of symptoms. Doebl et al. used the widespread pain index and symptom severity scale and determined that patients met the criteria of fibromyalgia if the sum of their scores on these two fibromyalgia measures was at least 12 out of 31.3

The investigators sent out a questionnaire and analyzed the responses from 85 individuals with a fibromyalgia diagnosis, 110 individuals who met the criteria for fibromyalgia but had not been diagnosed, and 133 individuals with chronic pain.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Results

The team compared the effect of symptoms and the healthcare use of people diagnosed with fibromyalgia with those who fulfilled the criteria for fibromyalgia but had not been diagnosed, as well as with those with chronic pain. The mean age across groups was similar, at 57–59 years, but the percentage of women in the groups differed markedly: 86% of those diagnosed with fibromyalgia were women; 64% who met the criteria for fibromyalgia but had not been diagnosed were women; and 67% of those with chronic pain and no diagnosis of fibromyalgia were women. These results suggest that although women and men are almost equally likely to meet the criteria for fibromyalgia, women are more likely to be diagnosed with fibromyalgia. Moreover, that diagnosis took a long time, with patients reporting that it took an average of three years from the onset of symptoms before they received a fibromyalgia diagnosis.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPain SyndromesResearch Rheum Tagged with:Arthritis Care & ResearchChronic painFibromyalgiaPainPain Managementpatient care

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Using Different Fibromyalgia Criteria Affects Prevalence Estimates

    September 14, 2021

    A recent paper illustrates how using different fibromyalgia criteria affects reports of its prevalence.1 Writing in Arthritis Care & Research, researchers found the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks–American Pain Society Pain Taxonomy (AAPT) criteria caused far more people to be categorized as having fibromyalgia than criteria put forth by…

    Treat-to-Target Strategy Evaluated for Fibromyalgia Care

    September 19, 2017

    Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences